Obstructive Sleep Apnea-hypopnea Syndrome
📧 Sign up to get email alerts when something new happens for Obstructive Sleep Apnea-hypopnea Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: The Role of Inflammatory Markers in OSAHS-Related White Matter Lesions and Asymptomatic Lacunar Infarction
A completed clinical trial investigated the role of inflammatory markers in obstructive sleep apnea-hypopnea syndrome–related white matter l…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Health Belief Model Nursing for Moderate to Severe OSAHS Post-Surgery [NA]
A completed clinical trial evaluated Health Belief Model nursing for moderate to severe obstructive sleep apnea-hypopnea syndrome after surg…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Assessment of the Occurrence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) in Women Suffering from Endometriosis
A clinical trial update evaluating the occurrence of obstructive sleep apnea-hypopnea syndrome in women with endometriosis. The study status…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Updating Deep Learning Algorithms for OSA Monitoring [NA]
A clinical trial update indicates Sky Labs is recruiting to update deep learning algorithms for monitoring obstructive sleep apnea.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A New Objective Titration Procedure for the Treatment of Mandibular Advancement Device in OSAHS Patients [NA]
Clinical trial update describes a new objective titration procedure for the use of a Mandibular Advancement Device in Obstructive Sleep Apne…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-06-21FDA Approved: MODAFINIL — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for a generic modafinil product (ANDA077667), enabling its marketing in the United Stat…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Effects of Myofunctional Therapy With an Application in Severe Apnea/Hypopnea Sleep Obstructive Syndrome (MTASSAOS) [NA]
Clinical trial update for MTASSAOS evaluating myofunctional therapy in severe obstructive sleep apnea-hypopnea syndrome; study status comple…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Prospective Study to Evaluate Outcomes From Transoral BOT Resection for OSAHS
A prospective trial evaluating outcomes from transoral base of tongue resection for obstructive sleep apnea/hypopnea syndrome was terminated…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Contribution of Drug Induced Sleep Endoscopy of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome
A completed clinical trial evaluated the contribution of drug-induced sleep endoscopy in pediatric obstructive sleep apnea hypopnea syndrome…
-
FDA approval · 2018-03-06FDA Approved: ARMODAFINIL — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's armodafinil as a generic product under an Original ANDA. It is indicated for excessive daytime sleep…
-
FDA approval · 2017-09-14FDA Approved: MODAFINIL — Original Application (Zydus Lifesciences Limited)
FDA approves the original generic application for modafinil by Zydus Lifesciences Limited.
-
FDA approval · 2017-08-16FDA Approved: MODAFINIL — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approves an original generic application for modafinil, manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc…
-
FDA approval · 2017-02-07FDA Approved: NUVIGIL — Supplemental Application (Cephalon, LLC)
FDA approved a supplemental application for NuVigil (armodafinil) submitted by Cephalon, LLC.
-
FDA approval · 2016-11-28FDA Approved: ARMODAFINIL — Original Application (Natco Pharma USA LLC)
The FDA approved Natco Pharma USA LLC's original application for armodafinil, enabling generic armodafinil to enter the market.
-
FDA approval · 2016-06-15FDA Approved: MODAFINIL — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Modafinil from Alembic Pharmaceuticals Limited. The approval confirms the ability to market the …
-
FDA approval · 2016-01-28FDA Approved: MODAFINIL — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for modafinil filed by Bionpharma Inc. to market a generic wakefulness-promoting drug.
-
FDA approval · 2016-01-20FDA Approved: ARMODAFINIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for armodafinil filed by Mylan Pharmaceuticals, granting regulatory approval for the indicated s…
-
FDA approval · 2015-02-09FDA Approved: NUVIGIL — Supplemental Application (Cephalon, LLC)
The FDA approved a supplemental application for Nuvigil (armodafinil) filed by Cephalon, LLC.
-
FDA approval · 2014-11-05FDA Approved: MODAFINIL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Modafinil submitted by Rising Pharma Holdings, Inc. The approval indicates the sponsor's supplem…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: New Markers to Measure Clotting in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome
This completed clinical trial examined biomarkers of fibrin clot structure and vascular endothelial injury in patients with obstructive slee…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: The Effect of the Mediterranean Diet on Obstructive Sleep Apnoea-Hypopnoea Syndrome: A Randomised Trial [NA]
This update summarizes a completed randomized trial evaluating the impact of the Mediterranean diet on obstructive sleep apnea-hypopnea synd…
-
FDA approval · 2014-02-03FDA Approved: MODAFINIL — Original Application (Apotex Corp.)
The FDA approved the original application for generic modafinil by Apotex Corp., authorizing their modafinil product as a generic version.
-
FDA approval · 2012-10-18FDA Approved: MODAFINIL — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's Original Application for Modafinil as a generic version of the wakefulness-promoting drug. Th…
-
FDA approval · 2012-06-01FDA Approved: ARMODAFINIL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for armodafinil from Mylan Pharmaceuticals Inc., enabling a generic version of the wakefulness-promotin…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Self-Reported Versus Objective Measured Compliance With Oral Appliance Therapy for Obstructive Sleep Apnea Hypopnea Syndrome
A completed trial comparing self-reported adherence to objective measurements for oral appliance therapy in obstructive sleep apnea-hypopnea…